首页> 外国专利> Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells

Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells

机译:使用睾丸外睾丸细胞将纳米颗粒靶向药物递送至肺

摘要

A method of delivering a compound of interest to the lungs of a subject by the intravenous injection of Sertoli cells loaded with a plurality of chitosan nanoparticles coupled with the compound of interest is provided. Testis-derived rat Sertoli cells were pre-loaded with chitosan nanoparticles coupled with or without the drug curcumin, pre-labeled with a fluorescent cell marker and then injected intravenously into the control or asthmatic mouse model host. Intact pre-loaded, pre-labeled Sertoli cells were present in the lungs at 15 minutes post-injection, appeared entrapped in the pulmonary pre-capillary vascular bed around alveolar sacs but were not present one hour post-injection although Sertoli cell label and cellular debris was. Most of the injected nanoparticle load (70%) and curcumin load (80%) was present in the lungs 15 minutes post-injection, and remained at 70% and 80%, respectively, one hour post-injection.
机译:提供了一种通过静脉内注射负载有多种壳聚糖纳米颗粒的Sertoli细胞将感兴趣的化合物递送至受试者的肺的方法,所述壳聚糖纳米颗粒与所述感兴趣的化合物偶联。将睾丸来源的大鼠Sertoli细胞预先加有壳聚糖纳米颗粒,并加或不加药物姜黄素,并用荧光细胞标记物预先标记,然后静脉内注射到对照或哮喘小鼠模型宿主中。注射后15分钟,完整的预加载,预先标记的Sertoli细胞出现在肺中,似乎被包裹在肺泡囊周围的肺毛细血管前血管床中,但注射后一小时不存在,尽管Sertoli细胞标记和细胞碎片是。注射后15分钟,大部分注射的纳米颗粒负荷(70%)和姜黄素负荷(80%)存在于肺部,注射后1小时分别保持在70%和80%。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号